Reid, M., Agbassi, Y.J.P., Arinaminpathy, N., Bercasio, A., Bhargava, A., Bhargava, M., Bloom, A., Cattamanchi, A., Chaisson, R., Chin, D. and Churchyard, G., 2023. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis. The Lancet.
Dierig, A., Hoelscher, M., Schultz, S., Hoffmann, L., Jarchow-MacDonald, A., Svensson, E.M., Te Brake, L., Aarnoutse, R., Boeree, M., McHugh, T.D. and Wildner, L.M., 2023. A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of different doses of delpazolid in combination with bedaquiline delamanid moxifloxacin in adult subjects with newly diagnosed, uncomplicated, smear-positive, drug-sensitive pulmonary tuberculosis. Trials, 24(1), pp.1-15.
Krause, R., Warren, C.M., Simmons, J.D., Rebeiro, P.F., Maruri, F., Karim, F., Sterling, T.R., Koethe, J.R., Leslie, A. and van der Heijden, Y.F., 2023. Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses. Frontiers in Immunology, 14, p.1151528.
Krause, R., Warren, C.M., Simmons, J.D., Rebeiro, P.F., Maruri, F., Karim, F., Sterling, T.R., Koethe, J.R., Leslie, A. and van der Heijden, Y.F., 2023. Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses. Frontiers in Immunology, 14, p.1151528.
Feldacker, C., Pienaar, J., Wasunna, B., Ndebele, F., Khumalo, C., Day, S., Tweya, H., Oni, F., Sardini, M., Adhikary, B. and Waweru, E., 2023. Expanding the Evidence on the Safety and Efficiency of 2-Way Text Messaging–Based Telehealth for Voluntary Medical Male Circumcision Follow-up Compared With In-Person Reviews: Randomized Controlled Trial in Rural and Urban South Africa. Journal of Medical Internet Research, 25, p.e42111.
van der Heijden, Y.F., Maruri, F., Blackman, A., Morrison, R., Guo, Y. and Sterling, T.R., 2023. Mycobacterium tuberculosis gene expression associated with fluoroquinolone resistance and efflux pump inhibition. The Journal of Infectious Diseases, p.jiad112.
Chimoyi, L., Kufa, T., Matsena-Zingoni, Z., Marx, F., Otwombe, K., Musenge, E. and Charalambous, S., 2023. Small area analysis of HIV viral load suppression patterns in a high priority district (2012–2016), South Africa. PLOS Global Public Health, 3(3), p.e0001728.
Beesham, I., Parikh, U.M., Mellors, J.W., Joseph Davey, D.L., Heffron, R., Palanee-Phillips, T., Bosman, S.L., Beksinska, M., Smit, J., Ahmed, K. and Makkan, H., 2022. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 91(2), pp.130-137.
